What question did this study set out to answer?

To evaluate the impact of a family pharmacist system on mortality and hospitalization risks in patients with chronic cardiovascular or endocrine diseases.

February 25, 2026Open Access

Family Pharmacist System for Patients With Chronic Cardiovascular or Endocrine Disease

Key Points

To evaluate the impact of a family pharmacist system on mortality and hospitalization risks in patients with chronic cardiovascular or endocrine diseases.
Conducted a large-scale cohort study
Analyzed the effects of FPS on patient outcomes
Focused on patients with chronic cardiovascular or endocrine disease
FPS was not linked to a lower risk of death or hospitalization overall
Hypothesis emerged suggesting FPS use may reduce mortality risk in older patients with chronic conditions

Abstract

This large-scale cohort study found that the use of an FPS was not associated with lower risk of death or hospitalization from any cause. However, the results generated a clinically important hypothesis that FPS use may be associated with slightly lower risk of death among older patients with chronic cardiovascular or endocrine disease.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Iketani et al. (Mon,) studied this question.

synapsesocial.com/papers/699e9152f5123be5ed04ecfc https://doi.org/https://doi.org/10.1001/jamanetworkopen.2025.60398

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper